The publication of over 100 genetic markers associated with depression has rocked the neuroscience community.

How a combinatorial approach to assessing coronary heart disease could improve diagnosis.

How inhibiting both polyamine synthesis (with DFMO) and uptake (with new small molecule AMXT 1501) could delay tumor development.

An iridium-based photodynamic drug accumulates in cancer cell nuclei – and destroys them from within.

China drafts new gene-editing regulations – but concerns over their enforcement remain.

The latest advances in translational medicine – condensed into 20-second servings.

Three leading lights in the neuro-oncology sphere explain what inspired them, how the field has evolved, and what challenges lie ahead.

New evidence suggests there’s more to metastasis than MMPs, demanding a therapeutic rethink.

How a new compound promises to selectively activate hepatic glucokinase in a bid to treat type 2 diabetes.

A novel protein platform helps neutralize powerful MRSA toxins.